Drug Costs

Get Help with Drug Costs

Search our list of programs to save on your medicine bills.
Eating WellEating Well
Learn how to eat well for optimal health and wellness.
Find New TreatmentsFind New Treatments
Discover if a clinical trial is right for you.
 
Feel Your BestFeel Your Best
Energize and strengthen with these safe exercise ideas.
No appetite?No Appetite?
Easy tips for getting the nutrition you need.
 
Community

Looking for Your Own Space to Communicate?

Set up a free, private website here, with the ability to control access.
Patient Stories Shining Lights
Read Jerry Womack’s and other survivors' stories.
Nurse`s CornerHair Dye and Chemo
Is it safe? Visit the Nurses’ Corner to find out.
 
Message Boards Message Boards
Connect with others and find answers to your questions.
4th Angel Network 4th Angel Network
Learn how to get or become a patient mentor.
 
 
Caring4Cancer Highlights

Share Your Story About Preventing InfectionShare Your Story About Preventing Infection

Help educate other patients by sharing your story about how you successfully helped prevent infection or managed infection during chemotherapy!. Click Here ...

NewsletterCaring4Cancer Enewsletters

Information and support that is tailored to the condition you have chosen, delivered free to your email. Subscribe Today...

Latest Cancer News
FDA Approves Votrient™ for Kidney Cancer

December 7, 2009 — On October 29, 2009 the FDA approved Votrient™ (pazopanib) for the treatment of advanced renal cell carcinoma (kidney cancer).

Home Care Nursing Improves Symptom Management

December 7, 2009 — Researchers from the UK have reported that symptom management for patients with breast and colorectal cancer treated with oral Xeloda® (capecitabine) was better for patients who received home care nursing than for patients receiving standard care. The results of this study appeared in an early online publication in the Journal of Clinical Oncology on November 16, 2009.

Cervarix® Vaccination Against HPV Lasts at Least Six Years

December 7, 2009 — Researchers affiliated with the GlaxoSmithKline Vaccine HPV-007 Study Group have reported that Cervarix® [human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine] has “high and sustained immunogenicity, and a favorable safety” profile for up to 6.4 years following administration. The details of this study appeared in an early online publication in the Lancet on December 3, 2009.

Risk of blood clots after surgery higher than thought

December 4, 2009 — NEW YORK (Reuters Health) - The risk of blood clots following surgery is probably higher - overall, more than one clot per 50 surgeries -- than previously thought, data from the UK's Million Women Study suggest.

Immediate biopsy unnecessary for some breast lumps

December 4, 2009 — NEW YORK (Reuters Health) - For breast lumps that can be felt with the fingers but look benign on ultrasound, an immediate biopsy may not be needed, particularly for some young women, researchers report.

Select news items provided by Reuters Health
Welcome to Caring4Cancer

Sign up with Caring4Cancer to create your personal web page, share with the community in our message boards, and track your treatments with our health tools. Learn more...

Sign Up Login
Meet Our Medical Advisors

Dr. William J. GradisharDr. William J. Gradishar
Northwestern University
Chicago, IL.